Phase Angle as a Marker of Muscle Damage, Muscle Fatigue and Inflammation, After Eccentric Exercise
1 other identifier
interventional
28
1 country
1
Brief Summary
The purpose of this study will be to assess the effectiveness of bioimpedance device (BIA) as a safe, rapid, and non-invasive method of analyzing muscle damage induced by high intensity induced eccentric exercise as an alternative measurement tool against traditional assessment methods. A sample of 28 sedentary subjects will be recruited, all participants will perform an eccentric exercise protocol. Measurements will be done before performing the exercise protocol, immediately after finishing the protocol, 3h after the end of the exercise protocol, 24h after the end of the exercise protocol and 48h after the end of the exercise protocol. The variables analyzed in all subjects will be phase angle, creatinkinase, jumping strength, VAS scale, white blood count cell, quadriceps muscle thickness, Borg scale and anxiety and depression questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 19, 2022
CompletedFirst Submitted
Initial submission to the registry
September 29, 2022
CompletedFirst Posted
Study publicly available on registry
October 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2023
CompletedOctober 17, 2022
September 1, 2022
3 months
September 29, 2022
October 13, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Phase angle
The phase angle, which is measured via bioelectrical impedance analysis (BIA), InBody 770 ,is a clinically important bioimpedance parameter used for nutritional assessment and evaluating the risk of various diseases. The phase angle was calculated automatically by the BIA device from these two components according to the following formula: phase angle (°) = (reactance/resistance) × (180°/π).
change from baseline to 72 hours
Secondary Outcomes (5)
Pain: VAS
change from baseline to 72 hours
Quadriceps thickness
change from baseline to 72 hours
Creatinkinase (CK concentration)
change from baseline to 72 hours
cellular inflammatory markers
change from baseline to 72 hours
Leg power
change from baseline to 72 hours
Study Arms (1)
Single group: excentric exercise protocol
EXPERIMENTALExcentric exercise protocol will be performed for all subjets, consisted of 10 sets of 20 repetitions of squats, jumping from a height of 50 cm
Interventions
Excentric exercise protocol will be performed for all subjets, consisted of 10 sets of 20 repetitions of squats, jumping from a height of 50 cm
Eligibility Criteria
You may qualify if:
- Healthy subjets
- Sedentary subjects
You may not qualify if:
- Trained subjects
- Subjects with musculoskeletal pathology
- Previous Surgeries in the last 6 months
- Subjects under pharmacological treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Francisco de Vitoria
Pozuelo de Alarcón, Madrid, 28223, Spain
Study Officials
- PRINCIPAL INVESTIGATOR
Jorge Buffet García
Universidad Francisco de Vitoria
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2022
First Posted
October 17, 2022
Study Start
September 19, 2022
Primary Completion
December 19, 2022
Study Completion
January 10, 2023
Last Updated
October 17, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share